Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab.
Saved in:
| Title: | Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab. |
|---|---|
| Authors: | Topalian SL; Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Brahmer JR; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland., Gettinger SN; Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut., Smith DC; Department of Internal Medicine, University of Michigan, Ann Arbor., McDermott DF; Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Sosman JA; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.; now with the Department of Medicine (Hematology and Oncology), Northwestern University Medical Center, Chicago, Illinois., Atkins MB; Department of Medicine, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts.; now with the Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia., Leming PD; The Christ Hospital Cancer Center, Cincinnati, Ohio., Spigel DR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee., Antonia SJ; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York., Wolchok JD; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York., Carvajal RD; Department of Medicine, Memorial Sloan Kettering Cancer Hospital, Weill Cornell Medical College, New York, New York.; now with the Department of Medicine, Columbia University Irving Medical Center, New York, New York., McHenry MB; Bristol-Myers Squibb, Princeton, New Jersey., Hosein F; Bristol-Myers Squibb, Princeton, New Jersey., Harbison CT; Bristol-Myers Squibb, Princeton, New Jersey., Grosso JF; Bristol-Myers Squibb, Princeton, New Jersey., Sznol M; Department of Internal Medicine (Section of Medical Oncology), Yale Cancer Center, New Haven, Connecticut. |
| Source: | JAMA oncology [JAMA Oncol] 2019 Oct 01; Vol. 5 (10), pp. 1411-1420. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
